{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:15:32Z","timestamp":1792613732367,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s12325-024-02980-0","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T06:02:24Z","timestamp":1726207344000},"page":"4299-4311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and Safety of Alpha-2 Agonists in Autism Spectrum Disorder: A Systematic Review"],"prefix":"10.1007","volume":"41","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail M.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Joseph Tremblay","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jada F.","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Potharaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpadevi","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4545-4523","authenticated-orcid":false,"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"10","key":"2980_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/01.NAJ.0000718628.09065.1b","volume":"120","author":"D Christensen","year":"2020","unstructured":"Christensen D, Zubler J. From the CDC: understanding autism spectrum disorder. Am J Nurs. 2020;120(10):30\u20137. https:\/\/doi.org\/10.1097\/01.NAJ.0000718628.09065.1b.","journal-title":"Am J Nurs"},{"key":"2980_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787.x01_Neurodevelopmental_Disorders","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Neurodevelopmental disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association Publishing; 2022. https:\/\/doi.org\/10.1176\/appi.books.9780890425787.x01_Neurodevelopmental_Disorders.","edition":"5"},{"issue":"11","key":"2980_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1474-4422(15)00044-7","volume":"14","author":"DH Geschwind","year":"2015","unstructured":"Geschwind DH, State MW. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 2015;14(11):1109\u201320. https:\/\/doi.org\/10.1016\/S1474-4422(15)00044-7.","journal-title":"Lancet Neurol"},{"key":"2980_CR4","unstructured":"CDC. Autism Data Visualization Tool. Centers for Disease Control and Prevention. 2023. https:\/\/www.cdc.gov\/ncbddd\/autism\/data\/index.html"},{"issue":"7","key":"2980_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028811","volume":"101","author":"X Jiang","year":"2022","unstructured":"Jiang X, Song M, Qin W, Xiao J, Xu X, Yuan Q. Nonpharmaceutical therapy for autism spectrum disorder. Medicine. 2022;101(7): e28811. https:\/\/doi.org\/10.1097\/MD.0000000000028811.","journal-title":"Medicine"},{"issue":"2","key":"2980_CR6","first-page":"110","volume":"29","author":"K Banas","year":"2020","unstructured":"Banas K, Sawchuk B. Clonidine as a treatment of behavioural disturbances in autism spectrum disorder: a systematic literature review. J Canad Acad Child Adolesc Psychiatry. 2020;29(2):110\u201320.","journal-title":"J Canad Acad Child Adolesc Psychiatry"},{"issue":"6","key":"2980_CR7","first-page":"389","volume":"40","author":"S LeClerc","year":"2015","unstructured":"LeClerc S, Easley D. Pharmacological therapies for autism spectrum disorder: a review. Pharm Ther. 2015;40(6):389\u201397.","journal-title":"Pharm Ther"},{"issue":"2","key":"2980_CR8","first-page":"130","volume":"21","author":"D Elbe","year":"2012","unstructured":"Elbe D, Lalani Z. Review of the pharmacotherapy of irritability of Autism. J Can Acad Child Adolesc Psychiatry. 2012;21(2):130\u201346.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"1","key":"2980_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010016.pub2","volume":"2017","author":"M Venables","year":"2017","unstructured":"Venables M, Ntzani E, Hsia Y, Gillies D. Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2017;2017(1): CD010016. https:\/\/doi.org\/10.1002\/14651858.CD010016.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2980_CR10","unstructured":"Norman K, Nappe TM. Alpha Receptor Agonist Toxicity. In: StatPearls. StatPearls Publishing. 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500023\/."},{"issue":"1","key":"2980_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","volume":"62","author":"JA Giovannitti","year":"2015","unstructured":"Giovannitti JA, Thoms SM, Crawford JJ. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog. 2015;62(1):31\u20138. https:\/\/doi.org\/10.2344\/0003-3006-62.1.31.","journal-title":"Anesth Prog"},{"issue":"1","key":"2980_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40122-018-0108-7","volume":"8","author":"JV Pergolizzi","year":"2019","unstructured":"Pergolizzi JV, Annabi H, Gharibo C, LeQuang JA. The role of lofexidine in the management of opioid withdrawal. Pain Ther. 2019;8(1):67\u201378. https:\/\/doi.org\/10.1007\/s40122-018-0108-7.","journal-title":"Pain Ther"},{"issue":"3","key":"2980_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.chc.2022.03.012","volume":"31","author":"G Joshi","year":"2022","unstructured":"Joshi G, Wilens TE. Pharmacotherapy of attention-deficit\/hyperactivity disorder in individuals with autism spectrum disorder. Child Adolesc Psychiatr Clin N Am. 2022;31(3):449\u201368. https:\/\/doi.org\/10.1016\/j.chc.2022.03.012.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"Suppl 1","key":"2980_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2165\/00023210-200923000-00006","volume":"23","author":"L Scahill","year":"2009","unstructured":"Scahill L. Alpha-2 adrenergic agonists in children with inattention, hyperactivity, and impulsiveness. CNS Drugs. 2009;23(Suppl 1):43\u20139. https:\/\/doi.org\/10.2165\/00023210-200923000-00006.","journal-title":"CNS Drugs"},{"issue":"5","key":"2980_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/cap.2006.16.589","volume":"16","author":"L Scahill","year":"2006","unstructured":"Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B. A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006;16(5):589\u201398. https:\/\/doi.org\/10.1089\/cap.2006.16.589.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"2980_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s13311-022-01183-1","volume":"19","author":"R Aishworiya","year":"2022","unstructured":"Aishworiya R, Valica T, Hagerman R, Restrepo B. An update on psychopharmacological treatment of autism spectrum disorder. Neurother: J Am Soc Exp NeuroTher. 2022;19(1):248\u201362. https:\/\/doi.org\/10.1007\/s13311-022-01183-1.","journal-title":"Neurother: J Am Soc Exp NeuroTher"},{"issue":"4","key":"2980_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","volume":"48","author":"JF Leckman","year":"1991","unstructured":"Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Gilles de la Tourette\u2019s syndrome. Arch Gen Psychiatry. 1991;48(4):324\u20138. https:\/\/doi.org\/10.1001\/archpsyc.1991.01810280040006.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2980_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/NDT.S1711","volume":"4","author":"BC Strange","year":"2008","unstructured":"Strange BC. Once-daily treatment of ADHD with guanfacine: patient implications. Neuropsychiatr Dis Treat. 2008;4(3):499\u2013506.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"2980_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/central\/CN-00082521","volume":"53","author":"MP Fankhauser","year":"1992","unstructured":"Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry. 1992;53(3):77\u201382. https:\/\/doi.org\/10.1002\/central\/CN-00082521.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"2980_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00004714-199210000-00005","volume":"12","author":"CA Jaselskis","year":"1992","unstructured":"Jaselskis CA, Cook EHJ, Fletcher KE, Leventhal BL. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol. 1992;12(5):322.","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"2980_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.braindev.2007.12.007","volume":"30","author":"X Ming","year":"2008","unstructured":"Ming X, Gordon E, Kang N, Wagner GC. Use of clonidine in children with autism spectrum disorders. Brain Develop. 2008;30(7):454\u201360. https:\/\/doi.org\/10.1016\/j.braindev.2007.12.007.","journal-title":"Brain Develop"},{"issue":"2","key":"2980_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/1044546041649084","volume":"14","author":"DJ Posey","year":"2004","unstructured":"Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol. 2004;14(2):233\u201341. https:\/\/doi.org\/10.1089\/1044546041649084.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"2980_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/DBP.0b013e3181739b9d","volume":"29","author":"BL Handen","year":"2008","unstructured":"Handen BL, Sahl R, Hardan AY. Guanfacine in children with autism and\/or intellectual disabilities. J Dev Behav Pediatr. 2008;29(4):303. https:\/\/doi.org\/10.1097\/DBP.0b013e3181739b9d.","journal-title":"J Dev Behav Pediatr"},{"issue":"12","key":"2980_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","volume":"172","author":"L Scahill","year":"2015","unstructured":"Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, Sanders R, Minjarez M, Cowen J, Mullett J, Page C, Ward D, Deng Y, Loo S, Dziura J, McDougle CJ. Extended-release guanfacine for hyperactivity in children with autism spectrum disorder. Am J Psychiatry. 2015;172(12):1197\u2013206. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15010055.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"2980_CR25","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41386-018-0039-3","volume":"43","author":"LC Politte","year":"2018","unstructured":"Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2018;43(8):1772\u20138. https:\/\/doi.org\/10.1038\/s41386-018-0039-3.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"issue":"12","key":"2980_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1097\/00004583-200212000-00010","volume":"41","author":"H Niederhofer","year":"2002","unstructured":"Niederhofer H, Staffen W, Mair A. Lofexidine in hyperactive and impulsive children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2002;41(12):1396\u20137. https:\/\/doi.org\/10.1097\/00004583-200212000-00010.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"2980_CR27","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/s0272-7358(00)00085-4","volume":"21","author":"W Gianarris","year":"2001","unstructured":"Gianarris W, Golden C, Greene L. The Conners\u2019 parent rating scales: a critical review of the literature. Clin Psychol Rev. 2001;21(7):1061\u201393. https:\/\/doi.org\/10.1016\/s0272-7358(00)00085-4.","journal-title":"Clin Psychol Rev"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02980-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-02980-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02980-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T18:09:13Z","timestamp":1729015753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-02980-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["2980"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-02980-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Alan D Kaye is an editorial board member of Pain and Therapy and Advances in Therapy. Dr. Alan D Kaye was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}